Public perspectives on disinvestments in drug funding: results from a Canadian deliberative public engagement event on cancer drugs

Public perspectives on disinvestments in drug funding: results from a Canadian deliberative public engagement event on cancer drugs

Abstract Background Decisions relating to the funding of new drugs are becoming increasingly challenging due to a combination of aging populations, rapidly increasing list prices, and greater numbers of drug-indication pairs being brought to market. This is especially true in cancer, where rapid lis...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarah Costa, Colene Bentley, Dean A. Regier, Helen McTaggart-Cowan, Craig Mitton, Michael M. Burgess, Stuart J. Peacock
Formato: Artículo
Lenguaje:English
Publicado: BMC 2019-07-01
Colección:BMC Public Health
Materias:
Priority setting
Cancer drug funding
Disinvestment
Public engagement
Acceso en línea:http://link.springer.com/article/10.1186/s12889-019-7303-2

Internet

http://link.springer.com/article/10.1186/s12889-019-7303-2

Ejemplares similares